Day 1 - Tuesday, September 30, 2014

7:15
Registration and Continental Breakfast
8:00
Co-Chairs’ Opening Remarks
8:15
Oyez, Oyez, Oyez!: Review of Key Supreme Court Cases that May Alter the Course of Paragraph IV Litigation
9:15
Brand Name and Generic Interpretations of The Changing Paradigm for Generic Market Entry: Identifying New Due Diligence Concerns Relative to ANDA Drug Targets and Anticipating New Paragraph IV Challenges
10:15
Morning Coffee Break
10:30
It’s All About Timing: Exploring the Surge in Premature Paragraph IV Notice Filings and Its Consequences
11:15
Teva v. Sandoz – A Debate on the Standard of Review for Claim Construction: De Novo vs. Deferential
12:30
Networking Luncheon
1:45
Exploring the Use of Reissue Applications to Amend Invalidity Findings in The District Courts
2:30
Afternoon Refreshment Break
2:45
Analyzing the Evolving Utilization of IPR and Other PTO Proceedings in Paragraph IV Litigation: Brand Name and Generic Perspectives
3:45
Understanding the Importance of Abiding by Local Rules: A Magistrate’s Perspective
4:45
A View From the Bench: The Judges Speak
6:00
Conference Adjourns to Day Two

Day 2 - Wednesday, October 1, 2014

7:15
Registration and Continental Breakfast
8:00
Co-Chairs’ Opening Remarks
8:15
Obviousness, Obliviousness and Obscurity: Exploring New Developments Double-Patenting Type Obviousness and Federal Circuit and PTO Discord on Obvious Findings Relative to Prior Art
9:15
Morning Coffee Break
9:30
Experts, Problems of Proof, Dispositive Motions and Markman Hearings: Addressing Common Dilemmas Encountered in A Paragraph IV Trial
11:00
Understanding How the Supreme Court’s Decision in Limelight v. Akamai Will Impact ANDA Litigation Involving Method of Treatment Patents
12:00
FTC Keynote: Reverse Payment Settlements and Other Antitrust Concerns Impacting Paragraph IV Litigation in the Wake of Actavis
1:00
Networking Luncheon
2:15
The Ever Shifting Boundaries of the Safe Harbor: Determining the Scope of 271 (e)(I) Protections Relative to Paragraph IV Litigation Post Classen and Momenta
3:00
New Exclusivity Challenges for Brand Names and Generics: Exploring Their Implications for Paragraph IV Challenges
3:45
Afternoon Refreshment Break
4:00
The Uncertain Future of At-Risk Launches: A Study of Injunctive Relief, Damages and the Impact of Protonix
5:00
Ethical Considerations for Paragraph IV Matters Before the PTO and District Courts: Looking Beyond Inequitable
5:45
Conference Adjourns